Oncternal Therapeutics Inc. (NASDAQ:ONCT) went up by 12.50% from its latest closing price compared to the recent 1-year high of $5.29. The company’s stock price has collected 5.88% of gains in the last five trading sessions.
Is It Worth Investing in Oncternal Therapeutics Inc. (NASDAQ :ONCT) Right Now?
Plus, the 36-month beta value for ONCT is at 1.74.
ONCT currently public float of 43.56M and currently shorts hold a 5.32% ratio of that float. Today, the average trading volume of ONCT was 926.32K shares.
ONCT’s Market Performance
ONCT stocks went up by 5.88% for the week, with a monthly jump of 52.75% and a quarterly performance of -14.29%, while its annual performance rate touched -75.77%. The volatility ratio for the week stands at 8.36% while the volatility levels for the past 30 days are set at 14.42% for Oncternal Therapeutics Inc. The simple moving average for the period of the last 20 days is 0.75% for ONCT stocks with a simple moving average of -45.98% for the last 200 days.
Analysts’ Opinion of ONCT
Many brokerage firms have already submitted their reports for ONCT stocks, with Oppenheimer repeating the rating for ONCT by listing it as a “Outperform.” The predicted price for ONCT in the upcoming period, according to Oppenheimer is $14 based on the research report published on April 07th of the previous year 2021.
Northland Capital, on the other hand, stated in their research note that they expect to see ONCT reach a price target of $21. The rating they have provided for ONCT stocks is “Outperform” according to the report published on February 23rd, 2021.
ONCT Trading at 16.88% from the 50-Day Moving Average
After a stumble in the market that brought ONCT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -76.18% of loss for the given period.
Volatility was left at 14.42%, however, over the last 30 days, the volatility rate increased by 8.36%, as shares surge +57.50% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +6.78% upper at present.
During the last 5 trading sessions, ONCT rose by +5.88%, which changed the moving average for the period of 200-days by -71.03% in comparison to the 20-day moving average, which settled at $1.2736. In addition, Oncternal Therapeutics Inc. saw -44.49% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at ONCT starting from VINCENT RICHARD G, who purchase 2,500 shares at the price of $1.40 back on Mar 28. After this action, VINCENT RICHARD G now owns 88,162 shares of Oncternal Therapeutics Inc., valued at $3,500 using the latest closing price.
VINCENT RICHARD G, the Chief Financial Officer of Oncternal Therapeutics Inc., purchase 2,497 shares at $1.48 during a trade that took place back on Mar 25, which means that VINCENT RICHARD G is holding 85,662 shares at $3,706 based on the most recent closing price.
Stock Fundamentals for ONCT
Current profitability levels for the company are sitting at:
- -726.91 for the present operating margin
- +96.08 for the gross margin
The net margin for Oncternal Therapeutics Inc. stands at -726.14. Equity return is now at value -38.60, with -36.40 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 16.99.